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ABSTRACT
Hox genes determine anterior–posterior specificity
of an animal body. In mammals, these genes map
onto four chromosomal loci in a clustered manner,
and their expression is regulated in a coordinated
manner according to their chromosomal structure.
In the present study, we analysed the Hoxb9
promoter and found that promoter activity in
cultured cells is linked to secondary structure
formation of promoter DNA. In nuclear extracts,
we also detected binding activity specific for
secondary-structured DNA. We successfully iso-
lated a candidate gene encoding this specific
DNA-binding protein, FBXL10, and demonstrated
the effects of the gene product on Hoxb9 promoter
activity. Our results suggest that DNA can regulate
gene expression by other, non-sequence-specific
modes of genetic coding.
INTRODUCTION
Many genes related to developmental processes have
temporally and spatially restricted expression proﬁles that
correspond to their roles during the development of
multicellular organisms. Failure to regulate a gene often
has deleterious consequences that may aﬀect the life of an
organism. Although much information exists on tran-
scription regulation, details of regulation mechanisms
taking place at the genome level remain elusive. Indeed, it
remains a mystery how countless enhancers and promo-
ters interact in an orderly fashion on a single macro-
molecule of DNA such as a chromosome.
Hox genes encode a group of transcription factors at
work during development. These factors are required
for anterior–posterior speciﬁcation of body segments. In
mammals, 39 Hox genes have been identiﬁed, and about
10 of these genes form a gene cluster on the same strand
of DNA. These gene clusters map onto four genomic loci
called HoxA, B, C and D complexes (1,2). These genes
show a characteristic genomic organisation in which the
order of their chromosomal transcription units mirrors
the spatial order of their expression domains along the
anterior–posterior axis of the developing embryo. Hox
genes located at the 30 extremity of the complex are
activated in anterior embryonic domains, whereas genes
located at progressively more 50 positions are transcribed
in more posterior areas. This phenomenon, called ‘spatial
colinearity’, was originally described in Drosophila and
further extended to all bilaterians exhibiting an anterior–
posterior axial polarity (3–6). A similar type of colinearity
can be observed over time in vertebrates such that Hox
genes located at the 30 extremity are activated earliest and
genes located at progressively more 50 positions are
transcribed later, according to their order on the genome
(7–9). Thus, ‘temporal colinearity’ is a characteristic of
Hox gene regulation in vertebrates.
The spatial and temporal regulation of the Hox
complex has been proposed to be a multi-step process,
with each step being initiated by progressive release from
heterochromatic silencing (8–10). Although the mechan-
istic basis of the progressive activation of genes is largely
unknown, we have demonstrated that interaction between
the 50-upstream region of the Hox complex and promoters
of resident Hox transcription units are important for early
silencing (8,9). To elucidate the mechanisms underlying
this higher-order regulatory system, we performed a
functional analysis of one key DNA element—the Hox
promoter. All mammalian Hox complexes are known to
contain 4th, 9th and 13th paralogous genes. Therefore, we
selected the Hoxb9 promoter as our study system based on
an assumption that DNA structures surrounding impor-
tant regions are better conserved than DNA structures in
functionally neutral regions. Here, we report that the
functional promoter fragment forms a secondary struc-
ture. We subsequently isolated factors that bind this
promoter.
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Cellcultures and luciferase activity assays
P19 cells were cultured as described previously (11). HeLa
cells and NIH3T3 cells were cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (Invitrogen) supplemented
with 10% heat-inactivated fetal bovine serum (JRH).
Luciferase assays were carried out with the Dual-
Luciferase Reporter Assay system (Promega). Hoxb9
upstream fragments were ligated into a pGL4.12 vector
(Promega). Transfection eﬃciency was monitored using a
Renilla reniformis luciferase reporter driven by a TK
promoter (pGL4.74, Promega). Cells were transfected
with constructs and siRNAs using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocols.
Chemiluminescence was measured with a luminometer
LB410 (Berthold Technologies, Inc.). Values are presented
as means and standard deviations of at least four
independent experiments.
RNAi
For RNAi, the siRNAs used were Stealth
TM RNAi
(Invitrogen) designed according to the manufacturer’s
protocol. The siRNA sequences against human FBXL
were as follows:
iRhF10, AAGUAAGUGAGACUGGAUCUCCACC;
iRhF11, UUGGCCACUGUACUAUAGGAACUCC.
To examine the eﬀects of these siRNAs on Hoxb9
promoter activity, we extracted total RNA from HeLa
cells with TRIzol (Invitrogen).
The siRNA sequences against mouse Fbxl were as
follows:
iRmF10-a,
AAGUAAGUGAGACUGGAUCUCCACC;
iRmF10-b, UUCACACUCACUUCUCCGCUUGGCA;
iRmF11, UAUAUUUGUUGGUUUGGAGCUUCUC.
Twenty-four hours after transfecting siRNA into P19
cells, we started retinoic acid (RA) treatment. We isolated
RNA 72h after siRNA transfection (48h after RA
treatment). First-strand cDNA synthesis was carried out
using 5mg of total RNA and SuperScript III First-Strand
Synthesis SuperMix (Invitrogen) according to the manu-
facturer’s instructions. We assessed Hox and Fbxl genes
expression in HeLa and P19 cells by real-time PCR
(RT–PCR) using a Corbett RG-3000 and Invitrogen
Platinum SYBRGreen PCR kit. We calibrated the real-
time PCR results by Rotor-Gene 6 Software (Corbett
Research) with standard cDNAs whose concentrations are
known. We also carried out real-time PCR with b-actin
as a control in HeLa and P19 cells.
We used the following primers in which the ﬁrst letter
of each primer—h or m—represent human or mouse,
respectively; hm primers are used both for human and
mouse.
hb-actin-F, TGGACATCCGCAAAGACCTG;
hb-actin-F, ACATCTGCTGGAAGGTGGAC;
mb-actin-F, CATGTTTGAGACCTTCAACAC;
mb-actin-R, GTGATGACCTGGCCGTCAGG;
mHoxb9-F, TTTGCGAAGGAAGCGAGGAC;
mHoxb9-R, AAGAGTGAGCTGGGGAAGGG;
hmFbxl10-F, CAAGGAGCAGAAGATGAACCG;
hmFbxl10-R, TGGGGCTTCTCGTATTTCCG;
hmFbxl11-F, ACTGCTGTCGGGTCTTCCACT;
hFBXL11-R, CGGTTTCCTGTTGAATCTGGG;
mFbxl11-R, GATTTTCCTGTTCAGTCTGGGC.
Gel mobility shiftassay
We performed electrophoretic mobility shift assay
(EMSA) as described previously (11). Nuclear extracts
were isolated as described previously (12). For competi-
tion studies, 12.5-, 25-, 50-, and 100-fold molar ratios of
cold DNA against the probe were added.
South-western screening
South-western screening was carried out according to the
procedure established by Vinson and colleagues (13), with
slight modiﬁcations. Instead of using 10
6c.p.m./ml of
probe, we used 10
4c.p.m./ml of probe in order to facilitate
the detection of speciﬁc binding to the probe. We isolated
55 clones after screening a P19 cDNA library and selected
one clone that displayed fragment A-speciﬁc binding,
but not fragment B-speciﬁc binding, upon further
South–western screening.
Antibodies
We generated a polyclonal antibody against FBXL10
by immunizing rabbits with a peptide corresponding
to amino acids 923–938 of mouse Fbxl10. Mouse
monoclonal antibody (mAb) to ubiquityl-histone H2A
and mouse mAb against FLAG were purchased from
Upstate and Sigma, respectively.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed based on a protocol
described previously (9). After P19 cells were cultured with
or without 0.3mM of RA for 48h in Petri dishes, we
collected the cells for ChIP assay. Immunoprecipitation
was performed with either anti-Fbxl10 or anti-ubiquityl-
histone H2A antibody. To isolate bound chromatin, we
used Dynabeads conjugated with Protein A and G for
anti-Fbxl10 antibody and Dynabeads rat anti-Mouse IgM
for ubiquitylated histone (Dynal Biotech). Samples were
washed, reverse crosslinked and digested with proteinase
K. Puriﬁed DNA samples were analysed by RT–PCR.
RESULTS
Correlation between promoter activity andsecondary
structure formation ofthe Hoxb9promoter
Transfection assays using P19, HeLa and NIH3T3 cell
lines demonstrated that Hoxb9 promoter activity required
a 289-bp fragment that contains the 274-bp fragment
upstream of the transcription initiation site ( 274 to
+15bp from transcription initiation site; fragment A in
Figure 1A and B). Shorter fragments (fragment B,  216
to +15bp; fragment C,  196 to +15bp) signiﬁcantly
decreased promoter activity (Figure 1A and B). These
results generally agree with those previously reported,
except that the diﬀerences in promoter activity between
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observed previously (11). This is probably because, in the
present study, we used a diﬀerent vector backbone in the
luciferase constructs and we used high-turnover luciferase
assays to assess promoter activity.
Although the promoter activities of fragments A and B
clearly diﬀered, EMSA and footprinting failed to show
that nuclear extracts contain binding activity on the
DNA spanning from positions  210 to  274 of promoter
fragment A (11). Instead, we found that the 296-bp frag-
ment A separated into multiple bands when electrophor-
esed on native polyacrylamide gels in the absence of
protein, while fragments B and C did not separate into
distinct multiple bands, suggesting that fragment A
becomes highly structured (Figure 2A), perhaps attaining
a secondary structure. We conﬁrmed by sequencing that
the multiple bands from fragment A share the same
sequence. This structural change may be responsible for
altering its mobility on EMSA gels. Similarly sized DNA
fragments, including fragments from  -phage and mam-
malian DNA such as those from the human c-myc
promoter, did not show similar heterogeneous mobility
patterns in native gels. Among the multiple bands derived
from fragment A, the mobility of the fastest-moving band
corresponded to the mobility of a same-sized linear DNA
fragment (289bp). To get insight into the secondary
structure of the slower-moving band, we conducted
digestion experiments with S1 nuclease and mung bean
nuclease, which enabled us to identify single-stranded
residues within the DNA fragment. The slower-moving
bands were much more sensitive to these nucleases than
the fastest-moving band (linear DNA fragment). These
results indicate that the slower-moving band contains
single-stranded residues. We could not detect, however,
signs of digestion at speciﬁc residues. The fragment
represented by the slow-moving band may contain multi-
ple sites that are sensitive to S1 nuclease digestion.
Alternatively, the strands close to the ends of this frag-
ment may have dissociated.
Although the detailed secondary structure of the Hoxb9
promoter fragment (fragment A) is yet to be determined,
we do know that this fragment contains a GC-rich region,
which is a prime candidate for triplex DNA formation.
To take on a triplex structure, however, this short DNA
fragment must be circular, not linear, in order to attain the
torsion needed for triplex formation; thus, the secondary
structure of this fragment is unlikely to be triplex (14).
Nevertheless, the link we observed between secondary
structure formation and promoter activity suggests that
secondary structure formation confers promoter activity
to the Hoxb9 fragment.
To examine secondary structure formation of the Hoxb9
promoter in another species and to conﬁrm the importance
of secondary structure formation, we also isolated the
corresponding fragment from the human genome. The
human counterpart of this fragment derived from the
HOXB9 promoter showed about 92% sequence identity to
the fragment derived from the MmHoxb9 promoter
(Supplementary Figure S1A) and exhibited more pro-
moter activity than the mouse promoter (data not
shown). Moreover, we also observed that the HsHOXB9
promoter fragment underwent secondary structure forma-
tion similar to that as the MmHoxb9 promoter fragment
(Supplementary Figure S1B). These results indicate that
the characteristic ability to undergo secondary structure
formation is conserved over species.
Specific binding activity againstsecondary structured
Hoxb9promoter in nuclear extracts
EMSA performed in the presence of nuclear extracts from
P19 and HeLa cells revealed that these extracts had
speciﬁc binding activity for the slow-moving band of
fragment A (Figure 2B). Although the slow-moving band
(arrows in Figure 2) disappeared when binding activity
was assessed in the presence of nuclear extracts
(Figure 2B), the fast-moving band (asterisks in Figure 2)
was unaﬀected (Figure 2B). These ﬁndings indicate that
binding activity was structure speciﬁc rather than
sequence speciﬁc, as the DNA represented by the fast-
moving and slow-moving bands shared identical
sequences. Although the addition of nuclear extracts
completely abolished the slow-moving band, no distinct
new bands were formed, suggesting that the DNA–protein
complex contained multiple proteins. To conﬁrm whether
the binding activity was speciﬁc, we performed competi-
tion assays using as competitors fragment A (which forms
the secondary structure) and fragment B (which showed
much less secondary structure formation) (Figure 2B).
Adding fragment A to the assay mixture caused the slow-
moving band (indicated by arrow in the Figure 2B) to
reappear, suggesting that DNA–protein complex is
dissociated by competition. On the other hand, adding
fragment B did not cause the slow-moving band to
reappear (Figure 2B). Taken together, these ﬁndings
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Figure 1. Luciferase assays of Hoxb9 promoter activity. (A) Diagram
of DNA fragments used for analysis. The top-most line represents a
map of the HoxB complex. We assessed the eﬀects of three diﬀerent
fragments (A, B and C) on promoter activity. (B) Relative luciferase
activities of promoter assay constructs in P19, HeLa and NIH3T3 cells.
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promoter, is capable of taking on a secondary structure;
and (ii) protein(s) in the nuclear extracts speciﬁcally bind
the secondary-structured fragment A.
Cloning ofsecondary-structured DNA-specific binding
protein
To determine the signiﬁcance of these ﬁndings, we
attempted to clone the secondary structured DNA-speciﬁc
binding protein(s). We isolated a clone after screening a
P19 cDNA library using the South–western method
(Figure 3A) (13) and veriﬁed its binding activity further
using EMSA (Figure 3B). Database searches revealed that
the clone is identical to Fbxl10, human PCCX2,
DKFZp434I0535 and JEMMA. Fbxl10 encodes an F-
box, a motif for E3 ubiquitin ligase (15). It also encodes a
bipartite nuclear localization signal (NLS) as well as
leucine-rich domains (Figure 3A). The presence of cxxc
and PHD-ﬁnger domains suggests that FBXL10 may be
related to chromatin modiﬁcation factors such as those
encoded by Polycomb-group (PcG) and trithorax-group
(trxG) genes. Recently, FBXL10 was identiﬁed as the
histone demethylase, JHDM1b, and several following
works reported that the jmjC domain is responsible for
histone demethylation activity (16–19). Thus, the presence
of a jmjC domain in Fbxl10 further supports the idea that
Fbxl10 participates in chromatin modiﬁcation.
Another Fbxl10 homologue, Fbxl11 (known as
JHDM1a), shares high homology with all the functional
domains of Fbxl10.
We fused in-frame the part of Fbxl10 containing the
cxxc and PHD ﬁnger domains with GST (heavy line in
Figure 3A), and subjected the resulting fusion protein to
EMSA. As with EMSA performed in the presence of
nuclear extracts, EMSA with the GST-fusion protein
resulted in a band shift similar to that of the slow-moving
band of fragment A (Figure 3B), however, without
yielding new discrete bands, only a smear. These ﬁndings
suggest that a homo–multimer complex formed around
the GST–Fbxl10 fusion protein. Moreover, fragment
A not B, successfully out-competed binding to the GST-
fusion protein as observed in the EMSA experiments
performed with nuclear extracts (Figure 3B). From these
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Figure 2. Hoxb9 promoter fragment forms a secondary structure. (A) Native gel electrophoresis of fragments A, B and C revealed that only the
fragment having promoter activity, fragment A, separated into multiple, but discrete, bands. Bands consisting of slow-moving secondary-structured
DNA are indicated by arrows, and bands consisting of fast-moving linear DNA are indicated by asterisks. (B) EMSA performed in the absence ( )
or presence (+) of nuclear extracts (NE) from P19 cells and competition assay for protein–DNA binding. Because a protein in the NE speciﬁcally
binds the highly structured DNA fragment (indicated by arrow), the slow-moving band disappeared and formed a smear (indicated by dotted line) in
the presence of NE, as shown in lanes 1 and 2. Lanes 3–10 show results from competition assays. The concentrations of competitor DNA used were
12.5-, 25-, 50- and 100-fold molar ratio relative to the probe (lanes 3 and 7; 4 and8; 5 and 9; 6 and 10, respectively). Adding fragment A as
a competitor caused the band (arrow) to reappear (lanes 3–6). Fragment B as a competitor, however, was much less eﬀective in causing the band
to reappear, indicating that fragment B failed to compete successfully.
1968 Nucleic Acids Research, 2008, Vol. 36, No. 6experiments, we concluded that Fbxl10 is likely to be the
DNA-binding protein within the nuclear extracts that
speciﬁcally bound the secondary-structured fragment A.
Effect ofsecondary-structured DNA-specific binding
protein onHoxb9 promoter activity
We performed a functional analysis of Fbxl10 and Fbxl11
using the RNAi gene-knockdown technique. We designed
siRNAs against human FBXL10 (iRhF10 siRNAs) and
FBXL11 (iRhF11 siRNAs) and examined the inﬂuence
of these siRNAs on Hoxb9 promoter activity by co-
transfecting them into HeLa cells with luciferase con-
structs containing fragment A. Transfection of FBXL10
and FBXL11 siRNAs reduced intrinsic FBXL10 and
FBXL11 expression (Figure 4). We observed cross-
repression of FBXL10 and FBXL11 by these siRNAs.
The siRNA iRhF10 eﬀectively reduced FBXL10 and
FBXL11 mRNA expression (Figure 4). Although
iRhF11 eﬀectively down-regulated FBXL11, it had a
relatively weak eﬀect on FBXL10. Luciferase activity
of the reporter construct containing fragment A showed
2.8-fold up-regulation compared to that of the control
when HeLa cells were co-transfected with the reporter
construct and iRhF10 (Figure 4). In contrast, luciferase
activity did not change signiﬁcantly when HeLa cells were
co-transfected with the construct and iRhF11 (Figure 4).
These results suggest that Fbxl10 is the primary factor
that inﬂuences Hoxb9 promoter activity. We could not
exclude, however, the inﬂuence of Fbxl11 on Hoxb9
promoter activity.
We further examined the eﬀects of Fbxl10 and Fbxl11
genes on the native Hox locus using P19 embryonal
carcinoma (EC) cell cultures. Although undiﬀerentiated
P19 cells showed little or no expression of Hoxb9 gene,
P19 EC cells express Hoxb9 gene when diﬀerentiation is
induced by RA treatment (11). To determine how Fbxl10
and Fbxl11 genes aﬀect the regulation of native Hoxb9
gene, we knocked down either Fbxl10 or Fbxl11 expres-
sion in RA-treated P19 cells with siRNA and measured
Hoxb9 gene expression by RT–PCR (Figure 5). Forty-
eight hours after RA induction, a time at which Hoxb9
gene is expressed (Figure 5) (11), Hoxb9 exhibited elevated
expression when Fbxl10 expression was suppressed by
treatment with Fbxl10-speciﬁc siRNA (iRmF10-a or
iRmF10-b) (Figure 5). Despite having a high degree of
sequence homology with Fbxl10, Fbxl11 in general did not
inﬂuence Hoxb9 expression (Figure 5; iRmF11). These
results support our hypothesis that Fbxl10 interacts
with the Hoxb9 promoter whereas Fbxl11 does not, even
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fragment A
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Figure 3. Cloning of Fbxl10, which encodes a protein that binds the highly structured Hoxb9 promoter fragment. (A) Scheme of cloning strategy and
schematic diagram of the obtained Fbxl10 gene. Cloning was done by using South–western methods and fragment A as a probe. The 55 clones we
isolated were counter-selected by South–western methods and fragment B as a probe. Further conﬁrmation was carried out with EMSA. We
obtained the partial sequence of Fbxl10 through South–western cloning. Sequence analysis of full-length Fbxl10 cDNA revealed several motifs: jmjC,
cxxc, Zn-ﬁnger, PHD Zn-ﬁnger and F-box domains and leucine-rich repeats (LRR). (B) EMSA with GST-fusion protein derived from the cloned
fragment. The fragment used to produce the GST-fusion protein is indicated as a bold black line located below Fbxl10 (panel A). Competition assays
were carried out as described in the legend of Figure 2. As observed with our EMSA analyses performed with nuclear extracts (NE) (see Figure 2),
fragment A competed successfully for binding, while fragment B did not. Arrow points to the slow-moving band; asterisk marks the band
representing linear DNA.
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Figure 5. Inﬂuence of Fbxl genes on the native Hoxb9 induction system. (A) The inﬂuences of Fbxl genes were analysed by introducing siRNAs. We
designed three siRNAs—iRmF10-a, iRmF10-b and iRmF11—and used RT–PCR to examine the eﬀects of these siRNAs on intrinsic Hoxb9 and Fbxl
expression. The siRNAs were introduced into P19 cells during the 24-h pre-incubation period and during the 48-h RA-induction period (total
exposure time: 72h). RT–PCR samples were normalized relative to b-actin expression. Transfection of Fbxl10-speciﬁc siRNAs elevated Hoxb9
expression (left graph), whereas transfection of Fbxl11-speciﬁc siRNAs did not signiﬁcantly inﬂuence Hoxb9 expression. The speciﬁcity of these
siRNAs on target genes is shown in the remaining graphs as indicated. (B) Binding of FBXL10 protein to native Hoxb9 promoter in P19 cells. ChIP
analysis revealed that FBXL10 binds Hoxb9 promoter in undiﬀerentiated P19 cells but not in diﬀerentiated P19 cells, which express Hoxb9.
(C) Histone H2A ubiquitylation status of the Hoxb9 promoter diﬀers as P19 cells diﬀerentiate. ChIP was carried out with anti-ubiquitylated histone
H2A antibody. Similar to the proﬁle observed for FBXL10, ubiquitylated histone H2A seems to accumulate at the Hoxb9 promoter region when P19
cells are in an undiﬀerentiated state.
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Figure 4. Eﬀects of FBXL genes on Hoxb9 promoter activity in HeLa cells. (A) Eﬀects of siRNAs on FBXL expression. We designed siRNAs—
iRhF10 and iRhF11—and used RT–PCR to examine the eﬀects of these siRNAs on Hoxb9 promoter activity. Speciﬁc siRNAs against FBXL10
increased promoter activity, whereas siRNAs speciﬁcally against FBXL11 either did not increase or weakly increased promoter activity.
(B) Treatment with siRNAs inﬂuences intrinsic FBXL expression. Each of these siRNAs down-regulated FBXL expression, as evident by the
deﬁnitive reduction of RT–PCR signals. RT–PCR samples were normalized relative to b-actin expression.
1970 Nucleic Acids Research, 2008, Vol. 36, No. 6though the structures of their protein products resemble
each other.
To examine the direct interaction between FBXL10
protein and the Hoxb9 promoter, we performed ChIP
assays using anti-FBXL10 antibody (Figure 5B). How-
ever, we observed FBXL10 binding onto the Hoxb9
promoter in undiﬀerentiated P19 cells. FBXL10 binding
to the Hoxb9 promoter disappeared in diﬀerentiated P19
cells, which express Hoxb9. These results correspond well
to our siRNA ﬁndings showing Fbxl10 repression activity
on the Hoxb9 promoter and strongly suggest that Fbxl10
is indeed a Hox regulator. To further investigate mechan-
isms underlying the regulation of Hoxb9 gene expression
during diﬀerentiation, we conducted ChIP assays using
various anti-histone antibodies. While we did not detect
diﬀerences in ChIP assays performed with anti-K9
acetylated histone H3, anti-K36 trimethylated histone
H3, anti-K36 dimethylated histone H3 and anti-K36
monomethylated histone H3 antibodies, we did detect
reduced binding to the Hoxb9 promoter when ChIP was
performed with anti-ubiquitylated histone H2A antibody
(Figure 5C). This reduced binding of ubi-H2A was similar
to the reduced binding of FBXL10 we observed in
diﬀerentiated P19 cells (Figure 5B). These observations
suggest the possibility that Fbxl10 functions as a histone
ubiquitylase not a histone demethylase during Hox
regulation.
Analysisof Fbxl10domains requiredfor regulation of
Hoxb9gene
To determine the importance of the cxxc and PHD
domains, which we used to make fusion proteins for
DNA-binding assays (Figure 3), we created several
mutants of Fbxl10 having either deletion or point
mutations in the jmjC domain, cxxc domain and/or the
PHD domain (Figure 6A). All of these mutant proteins
localized to the nucleus, as did wild-type Fbxl10
(Figure 6B). Next, to observe how these mutants inﬂuence
promoter activity, we introduced the constructs expressing
these mutants into HeLa cells along with a luciferase
reporter construct driven by Hoxb9 promoter fragment A.
Elevated expression of wild-type Fbxl10 down-regulated
luciferase activity (Figure 6C). Luciferase activity
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Figure 6. Assessment of domains involved in the speciﬁc regulation of Hoxb9.( A) Schematic diagrams of Fbxl10 mutants. J, C and P represent
deletion mutants of the jmjC domain, cxxc domain, and the PHD domain, respectively. CP represents a deletion mutant of both cxxc and PHD
domains. Three other mutants, pmJ, pmC, pmP and pmCP, have point mutations in jmjC, cxxc, PHD and both the cxxc and PHD domains,
respectively. (B) Subcellular localization of jcp1 mutants. Each mutant protein was fused with an HA-tag at C-terminal and then expressed in HeLa
cells. Fusion proteins were localized by immunocytochemistry with anti-HA antibody. All mutants localized to the nucleus. (C) Eﬀect of jcp1 mutants
on Hoxb9 promoter activity. We co-transfected HeLa cells with mutant-expressing plasmids and Hoxb9 luciferase reporter plasmids and examined
the inﬂuence of each mutation by measuring luciferase activity.
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construct (negative control) (Figure 6C). Both deletion
and point mutants of the cxxc domain (C, CP, pmC
and pmCP in Figure 6) failed to aﬀect luciferase activity,
whereas the mutants of the jmjC or PHD domains
inﬂuenced luciferase activity in a manner similar to wild-
type Fbxl10. Thus, the repressive activity of Fbxl10 was
completely abolished by mutations within the cxxc
domain, but mutations in the jmjC and PHD domains
did not inﬂuence the activity of Fbxl10 in this assay
system. We observed a similar eﬀect of Fbxl10 on human
HOXB9 promoter and similar loss of Fbxl10 repressive
activity resulting from point mutations in the cxxc domain
(Supplementary Figure 1C). Although we could not
demonstrate the importance of the jmjC and PHD
domains, these results indicated that the cxxc domain
plays a critical role in Fbxl10-mediated regulation of
Hoxb9.
The secondarystructure formation ofother Hoxpromoters
We expected that secondary structure formation was not
restricted to the Hoxb9 promoter; thus, we extensively
searched for other promoters within the Hox complex
capable of taking on secondary structures. We isolated
several DNA fragments containing the sequences sur-
rounding predicted transcription initiation sites of several
Hox genes and brieﬂy analysed the promoter activity
of these fragments by measuring luciferase activity
(Figure 7A and B). We identiﬁed several potential Hox
promoter fragments having lengths of about 300–700bp
(Figure 7B). These fragments clearly displayed promoter
activity when compared to that of the control luciferase
vector lacking a promoter, although most of these pro-
moters showed weaker activity than the Hoxb9 promoter
(Figure 7B). Some of these fragments with promoter
activity, such as Hoxd1 and Hoxd8, also showed hetero-
geneous mobility in native gels, as observed with Hoxb9
promoter fragment A (Figure 7C), although some frag-
ments from Hoxa1, Hoxa13 and Hoxb4 did not. At the
very least, these results suggest that promoter regions of
some Hox genes also have the potential to take on
secondary structures, as with the case of Hoxb9.A sw e
observed with Hoxb9, overexpression of Fbxl10 also
inﬂuenced the promoter activities of Hoxd1 and Hoxd8
(Figure 7D). In contrast, promoter fragments that did not
take on secondary structures, such as Hoxa1, Hoxa13 and
Hoxb4, did not inﬂuence promoter activity (Figure 7D).
Overexpression of Fbxl10 activated the Hoxd1 promoter
but repressed Hoxb9 and Hoxd8 promoters (Figure 7D).
Although we clearly observed a correlation between
secondary structure formation of Hox promoters and
Fbxl10, these results suggest that the Hox promoter
response to Fbxl10 varies.
DISCUSSION
Secondary structure formationof Hoxpromoters
We have previously proposed that multiple DNA–site
interactions are important for the coordinated expression
of Hox genes (8–10,20). This hypothesis also posited a
crucial role of regulated positional movement of chro-
mosomal loci in this Hox gene system. Recent reports
have emphasized the signiﬁcance of chromosomal position
within the nucleus during various biological processes
(21,22). Chambeyron and colleagues (23,24) demonstrated
the importance of chromosomal positioning of Hox genes
during development, correlating chromosomal position
with transcription activity. In this scheme, DNA–DNA
interactions (direct or indirect via protein–protein inter-
actions) can crucially determine the relative position
of DNA loci.
The mechanisms underlying chromosomal movement
remain completely unknown. However, it is clear that the
interaction between the repressive region (8) and promo-
ters of resident Hox genes are decisive factors in this
regulatory process. Here, we focused on the Hoxb9 pro-
moter and found a novel characteristic of Hox promoter
DNA—the Hox promoter forms secondary structures.
Although, the relationship between this phenomenon,
chromosomal movement and the formation of secondary
DNA structures remains to be determined, our results
suggest that the secondary structure formation of promo-
ter DNA is important for Hox gene regulation. Indeed,
we observed that several DNA fragments from Hox
complexes displayed a similar heterogeneity in mobility
when assessed in native gels, but DNA fragments from
non-Hox regions or other organisms, such as bacteria,
did not display this mobility shift (data not shown). The
nature of the higher structures formed by various Hox
promoter fragments remains elusive. However, it is
doubtful that these structures represent DNA triplets,
since the secondary structure of the short DNA fragments
we analysed was stable and detectable by native gel
electrophoresis. Even the linear form of this fragment
lacked the torsion derived from circular forms of DNA,
which is required for triplet formation (14). We believe
that the formation of secondary structures may be a
novel type of genetic coding, although secondary struc-
ture formation to some degree is dependent on DNA
sequence.
Secondary-structured DNA-specific bindingprotein and
gene transcription
Isolation of a clone (Fbxl10) encoding a protein that
speciﬁcally bound to a secondary-structured Hox promo-
ter fragment and determination of its inﬂuence on Hox
promoter activity shed light onto the signiﬁcant role of
secondary structures of promoter DNA in transcription
regulation. Furthermore, promoter analysis using other
Hox promoters indicated that Fbxl10 regulates multiple
Hox genes not just Hoxb9 gene. The molecular structure
of this protein suggests that it is a chromatin factor,
having shared homology with the cxxc and PHD Zn-ﬁnger
domains of PcG and trxG genes. The Fbxl10 and Fbxl11
genes also contain sequences encoding an F-box domain, a
protein motif found in a component of E3 ubiquitin ligase,
strongly suggesting that Fbxl10 and Fbxl11 proteins
participate in protein ubiquitylation processes. Recently,
histone ubiquitylation has been shown to be important
in histone modiﬁcations involved in transcription
1972 Nucleic Acids Research, 2008, Vol. 36, No. 6regulation (25). Indeed, Gearhart and colleagues (26)
suggested that FBXL10/JHDM1b is a component of the
BCOR (BCL6 corepressor) complex and is responsible for
histone H2A monoubiquitylation. In addition to these
motifs, Fbxl10 contains a leucine-rich repeat, indicating
that it may also interact with other proteins.
The presence of a jmjC domain in Fbxl10 further
supports the idea that it is involved in chromatin
modiﬁcation. Recently, Tsukada and colleagues (16)
reported that JHDM1a (Fbxl11 in the present work)
functions as a histone demethylase and that the jmjC
domain is responsible for histone demethylation activity.
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Figure 7. Higher structure formation of Hox promoters. (A) Examples of isolated Hox promoter fragments. Arrows indicate the 50 end of cDNA
sequences annotated in the NCBI sequence library. The transcription initiation site of Hoxb9 was determined previously (11). (B) Relative luciferase
activity of isolated promoter fragments. The promoter intensities of these fragments are shown relative to the luciferase activity measured in cells
transfected with Hoxb9 constructs, which was set to 100. The negative control (luciferase vector lacking a promoter fragment) did not show any
traces of activity. (C) Native gel electrophoresis of Hox promoter fragments. The fragments from Hoxa1, Hoxa13 and Hoxb4 did not exhibit multiple
bands, while the fragments from Hoxd1 and Hoxd8 separated into multiple bands, as observed with Hoxb9 (Figure 2). Asterisks mark linear portions
of the DNA fragments. (D) Eﬀects of Fbxl10 on Hox promoters. Each luciferase construct was co-transfected with an Fbxl10 expression construct.
Co-transfection experiments with the pmC construct represented control experiments (Figure 5). Overexpression of wild-type Fbxl10 inﬂuenced
luciferase activity in cells co-transfected with either Hoxd1 or Hoxd8 promoter fragments, fragments that take on a higher structure like Hoxb9.B y
contrast, wild-type Fbxl10 and pmC Fbxl10 failed to signiﬁcantly inﬂuence luciferase activity in cells co-transfected with Hoxa1, Hoxa13 or Hoxb4
promoter fragments. Asterisks indicate signiﬁcant diﬀerences compared to cells expressing the control vector according to the Student’s t-test
(P<0.03).
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JHDM1b) also has histone demethylase activity, since
Fbxl10 and Fbxl11 (JHDM1a) share high homology
throughout their molecular structures, including in their
jmjC histone demethylase domains (16). It is also probable
that Fbxl10 is involved in transcription activation
processes (16). The coexistence of demethylation activity
and ubiquitylation activity in one molecule, Fbxl10,
is somewhat controversial. Indeed, our analysis of the
Hoxd1 and Hoxb9 promoters suggests that Fbxl10 can
function diﬀerentially to activate or repress promoter
activity depending on the promoter or context. Multiple
domains of Fbxl10 and Fbxl11 proteins may be
involved in facilitating the protein–DNA or protein–
protein interactions required for complex transcription
regulation.
High homology in the molecular structures of Fbxl10
and Fbxl11 suggests that the products of these genes may
have functional similarities. However, Fbxl11 did not
signiﬁcantly inﬂuence Hoxb9 regulation in our transient
promoter assays or in our assessment of the transcription
proﬁle of the native Hoxb9 gene in P19 EC cells. These
results suggest that, despite their high homology, Fbxl10
and Fbxl11 diﬀer in their abilities to regulate downstream
genes.
The structural composition of Fbxl10 and Fbxl11
proteins (e.g. numerous domains for interacting with
other proteins) and the complexity of their activity on
transcription suggest that Fbxl10 and Fbxl11 proteins may
function as a structural ‘hub’ for a multi-protein–DNA
complex, and that they may also serve as a functional
‘hub’, coordinating diﬀerent functional protein complexes
for regulating gene transcription.
With regard to Hoxb9 transcription, in the present
study Fbxl10 likely functioned as a histone ubiquitylase
rather than a demethylase, because ChIP analysis showed
that ubiquitylated histone H2A diﬀerentially bound the
Hoxb9 promoter, a situation that reﬂects Hoxb9 expres-
sion during P19 EC cell diﬀerentiation. However, we also
observed that trichostatin A and butyrate abolished
Fbxl10-mediated repression of Hoxb9 promoter, suggest-
ing that HDAC (histone deacetylase) is also involved in
Hox regulation, as shown in the recently reported case of
c-jun (27). Recently, other jmjC proteins (Utx and JMJD3)
were identiﬁed as demethylase Hox regulators of K27
trimethylated histone H3 (28,29). According to these
schemes, at least three diﬀerent histone modiﬁcation
activities may intersect through Fbxl10. To fully under-
stand the regulatory role of Fbxl10, we need to continue
to analyse the regulatory mechanisms of Fbxl10 on Hox
genes.
Based on the present results, we propose an alternative
type of information coding in chromosomal DNA, one
that is based on secondary structure rather than on
sequence. Although the structure of DNA depends to
some degree on nucleotide sequence, we do not yet have
suﬃcient information to correlate sequence with structure.
However, the presence of proteins that speciﬁcally bind
secondary DNA structures and the potential role of these
proteins in gene transcription provide further support
for the importance of secondary structure formation in
DNA.
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